Exclusive Interview Released with Charles River Laboratories, Sponsors of Pharmaceutical Microbiology West Coast 2017
Pharmaceutical Microbiology West Coast 2017 will bring together industry experts from all around the world to discuss the recent changes within the microbiology field.
- (1888PressRelease) April 12, 2017 - SMi's Pharmaceutical Microbiology West Coast conference will take place in San Diego on the 8th and 9th June 2017.
SMi's Pharmaceutical Microbiology West Coast 2017 will bring together industry experts from across North America and the rest of the globe to discuss the recent changes within the microbiology field. The 7th event in the series will have a particular focus on rapid microbial methods as well as data integrity and the challenges in endotoxin recovery.
In the lead up to the event, SMi Group caught up with sponsor of the event, Charles River Laboratories for an exclusive interview. They spoke to speaker John Dubczak the Director of Operations about the current field of pharmaceutical microbiology and the challenges within the industry.
John will be providing a presentation on day one of the conference entitled 'Gram Negative LPS Structural Alterations in Response to Environmental Stimuli'. He will touch upon: How gram negative bacteria adapt to various environmental conditions; the role that modulation of outer membrane components has on facilitating environmental adaptation as well as discuss the effect that external stimuli and structural adaptation has on the classical LPS architecture.
Interview snapshot:
"SMi: How do you see the field of pharmaceutical microbiology progressing in the next 5-10 years?
JD: With biologics and biosimilars on the rise as an area of therapy, time is of the essence when it comes to releasing product. Due to shorter expiration dates as compared to traditional to small-molecule pharmaceuticals, some biologics may already be administered by the time traditional micro methods yield results. The ability to get a biological drug to market faster without sacrificing quality is paramount to ensure maximum treatment effectiveness. Implementing rapid microbiological methods is an effective and efficient way to shorten production cycle times, reduce manufacturing costs, expedite product time to market, and allow pharmaceutical companies to respond to immediate market demands. Additionally, the consensus we have seen among compendia and regulatory bodies on the validation of rapid microbiological methods, allows for continued technological innovation. All of the innovation with rapid microbiological methods rely on instrumentation. Given the current emphasis on data integrity, microbiological technology converges with regulatory expectations. The rapid technology measures, quantifies and records this addressing the data integrity issue that are becoming more apparent. From environmental monitoring to final sterility testing, data will be calculated and stored. The means to track and trend all microbiological data will be routine within 5 years."
For the full interview, visit the download centre of the event website. www.pharma-microbiology-usa.com/1888
Running alongside the conference will be two pre-conference workshops held on the 7th June.
WORKSHOP A: Technologies for Monitoring Contamination Control and Case Studies on Contamination Control. Hosted by Jim Polarine Jr, Senior Technical Service Manager, STERIS Corporation and Andrew Bartko, Research Leader, Battelle Memorial Institute.
WORKSHOP B: Microbial Required Use for Terminal Sterilization. Hosted by Jerry Dalfors, Principal, JD Technologies
For those wanting to attend, there is currently an early bird offer available; book by 28th April to save $100 off the conference price. Register at www.pharma-microbiology-usa.com/1888
Pharmaceutical Microbiology West Coast is sponsored by Charles River Laboratories, Rapid Microbiosystems and Biomerieux
For sponsorship packages: Contact Alia Malick +44 (0) 207 827 6168 or e-mail amalick ( @ ) smi-online dot co dot uk dot
For delegate enquiries: Contact Fateja Begum on +44 (0) 20 7827 6184 or email
fbegum ( @ ) smi-online dot co dot uk
For media enquiries, contact Kafayat Obanigba on +44 (0) 20 7827 6140 or kobanigba ( @ ) smi-online dot co.uk
Pharmaceutical Microbiology USA
8 - 9 June 2017
San Diego, California, USA
www.pharma-microbiology-usa.com/1888
Contact e-mail: kobanigba ( @ ) smi-online dot co.uk
Contact tel: +44 (0) 207 827 6184
#smimicrobiology
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam